book chapter · Advances in bioinformatics and biomedical engineering book series
Although the pathophysiology of Alzheimer's disease (AD) is exceedingly complex and poorly understood, the illness is nonetheless of great interest to the scientific community. Recent advances in AD research have allowed for the possibility that further treatment advantages might be found, which would assist patients all around the world. However, recent studies suggest that glial cells, such as microglia, astrocytes, oligodendrocytes, and oligodendrocyte progenitor cells (NG2 glia), are linked to the pathogenesis of AD and may offer several potential therapeutic targets against AD. Previous research on AD has focused primarily on neurons. Glial cells are essential to the structural integrity of neurons and are necessary for regulating homeostasis (concentration of ions, neurotransmitters) within the central nervous system. This chapter investigates the following topics: (i) the function of glial cells in the pathogenesis of AD; (ii) the intricate functions of the constituent parts; and (iii) prospective therapeutic targets that may one day improve the quality of life for AD patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4018/978-1-6684-9675-6.ch015
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.